Ovarian Cancer
A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients with Solid Tumors Likely to Express NaPi2b (MER-XMT-1536-1)
- Details
ClinicalTrials.gov ID:
NCT03319628
Diagnosis Type:
NA
USOR Number:
- Address
10107 RidgeGate Parkway, Suite 200
Lone Tree, CO 80124
P: (303) 925-0700